Sarah Cannon Cancer Institute - HCA Midwest — Overland Park, Kansas

Sarah Cannon Cancer Institute - HCA Midwest is a clinical research site located in Overland Park, Kansas, United States 66211.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Institute - HCA Midwest has participated in 1 clinical trials.

Therapeutic areas: Neurofibromatosis Type 2.

Sponsors: Recursion Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Institute - HCA Midwest?

Sarah Cannon Cancer Institute - HCA Midwest has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Institute - HCA Midwest conducted?

Sarah Cannon Cancer Institute - HCA Midwest has 1 clinical trials on record. Their work covers Neurofibromatosis Type 2.

Is Sarah Cannon Cancer Institute - HCA Midwest accredited by Crixeo Health?

Sarah Cannon Cancer Institute - HCA Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Institute - HCA Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.